Miriam J. Paramore

This profile gathers the share dealings of Miriam J. Paramore in OptimizeRx Corp, where the filings describe the role as chief executive. The record holds 9 filings, for trades running from 17 May 2021 to 2 December 2021.

Sales make up the whole of the open-market record (3 sales, €794k). The rest of the record consists of 6 option exercises.

The record was last updated on 3 December 2021 with an open-market sale (€193k) in OptimizeRx Corp. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.